You just read:

Alzheimer's Weekly names ANAVEX 2-73 the number one most promising trial drug in Alzheimer's disease and Anavex's Phase I clinical program as "Trial of the Year"

News provided by

Anavex Life Sciences Corp.

Jan 06, 2011, 09:00 ET